# Targeted Pediatric High-Grade Glioma Therapy

> **NCT05839379** · — · RECRUITING · sponsor: **Nationwide Children's Hospital** · enrollment: 350 (estimated)

## Conditions studied

- High Grade Glioma
- Diffuse Intrinsic Pontine Glioma
- Anaplastic Astrocytoma
- Glioblastoma
- Glioblastoma Multiforme
- Diffuse Midline Glioma, H3 K27M-Mutant
- Metastatic Brain Tumor
- WHO Grade III Glioma
- WHO Grade IV Glioma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05839379
- **Lead sponsor:** Nationwide Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-02
- **Primary completion:** 2029-08-28
- **Final completion:** 2034-08-28
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05839379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05839379, "Targeted Pediatric High-Grade Glioma Therapy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05839379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*